Stocknear Logo Stocknear
/
Popular
Login

Allurion Technologies Inc...

3.20
0.00 (0.00%)
At close: Mar 28, 2025, 3:59 PM
3.05
-4.64%
After-hours: Mar 28, 2025, 06:40 PM EDT
0.00%
Bid 3.05
Market Cap 19.08M
Revenue (ttm) 73.94K
Net Income (ttm) -60.22K
EPS (ttm) -291
PE Ratio (ttm) -0.01
Forward PE -0.75
Analyst Buy
Ask 3.26
Volume 286,842
Avg. Volume (20D) 2,868,337
Open 3.35
Previous Close 3.20
Day's Range 3.08 - 3.37
52-Week Range 2.15 - 98.75
Beta -0.63

About ALUR

Allurion Technologies Inc. focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform, the Allurion Program, features swallowable and procedure-less intragastric balloon for weight loss (the Allurion Balloon) and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion Virtual Care Suite....

[Show more]
Industry Medical - Devices
Sector Healthcare
IPO Date Mar 29, 2021
Employees 501
Stock Exchange NYSE
Ticker Symbol ALUR
Website https://www.allurion.com
Full Company Profile

Analyst Forecast

According to 3 analyst ratings, the average rating for ALUR stock is "Buy." The 12-month stock price forecast is $16, which is an increase of 400.00% from the latest price.

Stock Forecasts

Earnings Surprise

Allurion has released their quartely earnings on Mar 26, 2025:
  • Revenue of $5.59M misses estimates by $9K, with -32.11% YoY decline.
  • EPS of -7.95 misses estimates by -2.95, with 20.50% YoY growth.

    • Next Earnings Release

    Allurion Technologies Inc. is scheduled to release its earnings on May 13, 2025, before market opens.
    Analysts project revenue of ... Unlock content with Pro Subscription

    Why Price Moved

    Why Price Moved is a one-sentence explanation of why a stock is moving higher or down. By removing noise and collecting signals from news, press releases and SEC filings, we can pinpoint the trigger for price movements.
    1 week ago
    +57.02%
    Allurion Technologies shares are trading higher af... Unlock content with Pro Subscription
    1 week ago
    -5%
    Allurion Technologies shares are trading higher after the company announced results from its allurion program and low-dose GLP-1 therapy combination.
    news image

    2 days ago · seekingalpha.com

    Allurion Technologies Inc. (ALUR) Q4 2024 Earnings Call Transcript

    Allurion Technologies Inc. (NYSE:ALUR ) Q4 2024 Earnings Conference Call March 26, 2025 8:30 AM ET Company Participants Mike Cavanaugh - Investor Relations Shantanu Gaur - Founder and Chief Executive ...

    news image

    2 days ago · zacks.com

    Allurion Technologies, Inc. (ALUR) Reports Q4 Loss, Lags Revenue Estimates

    Allurion Technologies, Inc. (ALUR) came out with a quarterly loss of $7 per share versus the Zacks Consensus Estimate of a loss of $5. This compares to loss of $15.75 per share a year ago.

    news image

    2 days ago · businesswire.com

    Allurion Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides Business Update

    NATICK, Mass.--(BUSINESS WIRE)---- $ALUR--Allurion Technologies, Inc. (NYSE: ALUR) (“Allurion” or the “Company”), a company dedicated to ending obesity, today announced its financial results for the f...

    news image

    1 week ago · businesswire.com

    Allurion Announces Initial Results on the Combination of the Allurion Program With Low-dose GLP-1 Therapy to Optimize Muscle Mass and GLP-1 Adherence

    NATICK, Mass.--(BUSINESS WIRE)---- $ALUR--Allurion Technologies, Inc. (“Allurion” or the “Company”) (NYSE: ALUR), a company dedicated to ending obesity, today announced initial results on the combinat...

    news image

    3 weeks ago · businesswire.com

    Allurion Announces Notification of Issuance of New U.S. Patents on Next-Generation Weight Loss Device for the Treatment of Obesity

    NATICK, Mass.--(BUSINESS WIRE)---- $ALUR--Allurion Technologies, Inc. (“Allurion” or the “Company”) (NYSE: ALUR), a company dedicated to ending obesity, today announced that it has received two Issue ...

    news image

    1 month ago · businesswire.com

    Allurion Announces Plans To Combine GLP-1 Therapy With The Allurion Balloon to Treat Obesity

    NATICK, Mass.--(BUSINESS WIRE)---- $ALUR--Allurion Technologies, Inc. (“Allurion” or the “Company”) (NYSE: ALUR), a company dedicated to ending obesity, today announced its intention to initiate a cli...

    news image

    1 month ago · businesswire.com

    Allurion Relaunches in France

    NATICK, Mass.--(BUSINESS WIRE)---- $ALUR--Allurion Technologies, Inc. (“Allurion” or the “Company”) (NYSE: ALUR), a company dedicated to ending obesity, today announced that it is relaunching the Allu...

    news image

    1 month ago · zacks.com

    How Much Upside is Left in Allurion Technologies, Inc. (ALUR)? Wall Street Analysts Think 374.67%

    The mean of analysts' price targets for Allurion Technologies, Inc. (ALUR) points to a 374.7% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agr...

    news image

    2 months ago · benzinga.com

    Allurion Technologies Shares Are Up Today: What's Going On?

    Allurion Technologies ALUR shares are moving higher Friday, potentially in response to the company's Thursday announcement of a planned clinical study to evaluate the combination of its Allurion Progr...

    news image

    2 months ago · investopedia.com

    Allurion Stock Triples on Plan to Test Gastric Balloon With Obesity Drugs

    Shares of Allurion Technologies (ALUR) tripled Friday as the maker of the Allurion Gastric Balloon weight-loss device looked to take advantage of the booming obesity drug market.

    Create Price Alert on ALUR

    Your price alert will notify you when the stock price is above 3.2.

    Add to Watchlist